🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHas anyone dealt with rybelsus 14mg real-world experience thread? Page 5

Has anyone dealt with rybelsus 14mg real-world experience thread?

laura_annarbor Thu, Mar 21, 2024 at 8:18 PM 29 replies 2,364 viewsPage 5 of 6
fiona_glasgow
Member
312
1,345
Aug 2024
Glasgow, UK
Mar 25, 2024 at 4:41 AM#21
DebRD_ATL said:
Worth answering the question that was asked rather than the one behind it.

Coming at DebRD_ATL’s question from a different direction. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

Ask again with the specifics and you will get a better answer than this one.

16 16TrialTracker_MD, JennaRN, LabKate and 13 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Mar 25, 2024 at 8:14 PM#22

The figures, for anyone assembling their own picture. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

15 15anna.melb_AU, mark_tokyo, hans_munich and 12 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Mar 26, 2024 at 11:47 AM#23

One thing that is still open after DebRD_ATL’s answer:

How to read a result like this without either dismissing it or over-reading it, since the summaries all read like press releases?

14 14EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 11 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Mar 27, 2024 at 3:21 AM#24
Dr.RaviCardio said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

Last edited: Mar 27, 2024 at 8:21 AM
13 13pete_nash, hank_denver, carlos_SATX and 10 others
Reply Quote Save Share Report
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Mar 27, 2024 at 6:55 PM#25
Dr.RaviCardio said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

Ask again with the specifics and you will get a better answer than this one.

12 12VanRx_Mike, steve_okc, dave_SLC and 9 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register